What is the current Price Target for the Applied Therapeutics, Inc. stock?

The average Applied Therapeutics, Inc. target price is $4.50. This is 427.36% higher than the current stock price. The highest price target is 837.54%, the lowest is 75.79%. 5 Analysts have issued a price target Applied Therapeutics, Inc. 2025 .

How high will the Applied Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Applied Therapeutics, Inc. stock will rise. The performance of stocks, including the Applied Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Applied Therapeutics, Inc. stock today?

The performance of Applied Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Applied Therapeutics, Inc. stock fall?

The decline in Applied Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Applied Therapeutics, Inc. Forecast, price target & analysts

$0.81

5.05% today

Nasdaq, Dec 30, 09:18 pm CET

ISIN

US03828A1016

Symbol

APLT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Applied Therapeutics, Inc. Target price 2024 - Analyst rating & recommendation

Applied Therapeutics, Inc. Classifications & Recommendation:

Buy

50%

Hold

50%

Applied Therapeutics, Inc. Price Target

Target Price	$4.50
Price	$0.85
Potential	427.36% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Applied Therapeutics, Inc. 2025 . The average Applied Therapeutics, Inc. target price is $4.50. This is 427.36% register free of charge higher than the current stock price. The highest price target is $8.00 837.54% register free of charge , the lowest is $1.50 75.79% register free of charge .
	A rating was issued by 6 analysts: 3 Analysts recommend Applied Therapeutics, Inc. to buy, 3 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Applied Therapeutics, Inc. stock has an average upside potential 2025 of 427.36% register free of charge . Most analysts recommend the Applied Therapeutics, Inc. stock at Buy or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-1.42	-1.28
	34.86%	9.86%
P/E		negative
EV/Sales		4.59

Based on analysts' sales estimates for 2024, the Applied Therapeutics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

Unlock

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	-2.13	111.09%
2024	4.59 315.51% Unlock
2025	0.18 96.00% Unlock
2026	0.04 77.45% Unlock
2027	0.04 5.31% Unlock
2028	0.02 51.79% Unlock

Current	9.31	58.79%
2024	190.70 1,947.36% Unlock
2025	7.63 96.00% Unlock
2026	1.72 77.46% Unlock
2027	1.63 5.38% Unlock
2028	0.78 51.80% Unlock

Applied Therapeutics, Inc....

Discover more stocks with a high price target

Valneva 268.86%

CureVac N.V. 114.53%

Moderna 77.92%

Bavarian Nordic 59.49%

Teamviewer 56.15%

RWE 47.84%

Nel ASA 47.09%

Alibaba Group Holding Ltd 43.74%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now